Efficacy and safety of immune checkpoint inhibitors and targeted therapies in resected melanoma: a systematic review and network meta-analysis

Background: Multiple immune checkpoint inhibitors (ICIs) and targeted therapies have been widely used as adjuvant treatments for high-risk resected melanoma, with unclear comparative efficacy and safety. Methods: PubMed, Embase, the Cochrane Library, and ClinicalTrials.gov were searched from databas...

Descripción completa

Detalles Bibliográficos
Autores principales: Sheng, Feng, Yan, Yulan, Zeng, Baoqi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10661889/
https://www.ncbi.nlm.nih.gov/pubmed/38026956
http://dx.doi.org/10.3389/fphar.2023.1284240

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10661889/
https://www.ncbi.nlm.nih.gov/pubmed/38026956
http://dx.doi.org/10.3389/fphar.2023.1284240

Ejemplares similares